Locate Bio

Executive Summary

Locate Bio is a UK-based MedTech company founded in 2016, specializing in next-generation orthobiologic products for musculoskeletal repair. The company leverages industry-leading drug delivery and tissue scaffold capabilities to develop advanced bone graft solutions. Its mission is to provide surgeons with best-in-class products that relieve suffering and restore patients' quality of life. Locate Bio operates at the intersection of regenerative medicine and orthopedics, addressing a significant unmet need in bone healing and spinal fusion. The company's platform technology enables controlled release of growth factors and osteoinductive materials, potentially improving patient outcomes and reducing complications compared to traditional bone grafts. While still in a private stage with limited public information, Locate Bio has attracted attention within the cell and gene therapy space, though its specific pipeline stage remains undisclosed. The company's focus on musculoskeletal repair positions it in a large and growing market driven by aging populations and increasing orthopedic procedures. Locate Bio's ability to scale its platform and secure regulatory approvals will be critical to its success.

Upcoming Catalysts (preview)

• TBDInitiation of a Pivotal Clinical Trial for Lead Orthobiologic Product60% success
• TBDSecuring Series B or Later Funding Round70% success
• TBDStrategic Partnership with Major Orthopedics Company50% success